West Pharmaceutical Services Inc (WST)

Currency in USD
239.26
0.00(0.00%)
Closed·
After Hours
239.260.00(0.00%)
·

WST Financial Summary

Key Ratios

P/E Ratio35.66
Price/Book6.33
Debt / Equity10.52%
Return on Equity17.72%
Dividend Yield0.37%
EBITDA749.00M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.73%
Dividend Yield
0.37%
Industry Median 1.32%
Annualised payout
0.88
Paid quarterly
5-Years Growth
+5.67%
Growth Streak

Analyst Ratings

11 Buy
2 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 316.36
(+32.23% Upside)

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
1.84 / 1.51
Revenue / Forecast
766.50M / 725.26M
EPS Revisions
Last 90 days

FAQ

What were West Pharmaceutical Services's earnings for the latest quarter?

The West Pharmaceutical Services EPS (TTM) is 6.73. West Pharmaceutical Services reported sales of 766.50, net income of 131.80, and EPS of 1.84 for the latest quarter.

What was West Pharmaceutical Services's net income for the latest quarter?

West Pharmaceutical Services's net income for the latest quarter was 131.80.

How did West Pharmaceutical Services's performance compare year-over-year in the latest quarter?

The company's revenue moved from 698.00 in the previous quarter to 766.50 in the latest quarter, and net income moved from 89.80 to 131.80 compared to the previous quarter.

What is West Pharmaceutical Services's net profit margin on a TTM basis?

West Pharmaceutical Services's trailing twelve months (TTM) net profit margin is 17.03%.

How does West Pharmaceutical Services's debt to equity ratio compare to industry standards?

West Pharmaceutical Services's total debt-to-equity ratio is 10.52%.

What is West Pharmaceutical Services's return on investment on a TTM basis?

West Pharmaceutical Services's trailing twelve months (TTM) return on investment (ROI) is 17.72%.

Did West Pharmaceutical Services gain or lose cash last quarter?

In the latest quarter, West Pharmaceutical Services's net change in cash was 105.50 million.

What were West Pharmaceutical Services's total assets and liabilities in the latest quarter?

As of the latest quarter, West Pharmaceutical Services reported total assets of 3,952.80 million and total liabilities of 604.60 million.

How has West Pharmaceutical Services's total revenue grown this year?

West Pharmaceutical Services's total revenue was 698.00 in the previous quarter and 766.50 in the latest quarter.

What is West Pharmaceutical Services's gross margin on a TTM basis?

West Pharmaceutical Services's trailing twelve months (TTM) gross margin is 35.27%.

What was West Pharmaceutical Services's revenue per share for the latest quarter?

West Pharmaceutical Services's revenue per share for the latest quarter was 31.68.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.